Importantly, we noted that the above process of TRAF4 nuclear translocation could be inhibited by LOXO‐101, an NGFR inhibitor that has been approved for the treatment of metastatic solid tumors regardless of the site of tumor occurrence. This evidence concerns the gene NGFR and neoplasm.